Sana Biotechnology, Inc. (SANA)
2.89
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
2.90
+0.01
(+0.35%)
After-Hours: 20:00
Sana Biotechnology Net Income (Quarterly) : -63.64M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -63.64M |
| March 31, 2026 | -47.21M |
| December 31, 2025 | -58.82M |
| September 30, 2025 | -42.15M |
| June 30, 2025 | -93.80M |
| March 31, 2025 | -49.39M |
| December 31, 2024 | -49.07M |
| September 30, 2024 | -59.92M |
| June 30, 2024 | -50.29M |
| March 31, 2024 | -107.48M |
| December 31, 2023 | -88.12M |
| September 30, 2023 | 0.984M |
| June 30, 2023 | -114.00M |
| Date | Value |
|---|---|
| March 31, 2023 | -82.12M |
| December 31, 2022 | -80.44M |
| September 30, 2022 | -85.12M |
| June 30, 2022 | -72.46M |
| March 31, 2022 | -31.45M |
| December 31, 2021 | -110.73M |
| September 30, 2021 | -83.26M |
| June 30, 2021 | 18.68M |
| March 31, 2021 | -180.62M |
| December 31, 2020 | -113.17M |
| March 31, 2020 | -32.88M |
| December 31, 2019 | -43.04M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -106.63M |
| Twist Bioscience Corp. | -35.05M |
| Beam Therapeutics, Inc. | -122.68M |
| Prime Medicine, Inc. | -42.11M |
| Revolution Medicines, Inc. | -644.37M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 63.64M |
| EPS Diluted (Quarterly) | -0.2152 |
| Enterprise Value | 774.05M |
| Earnings Yield | -26.32% |
| Normalized Earnings Yield | -23.48 |